Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Buspirone name brand?Goodrx modafinil 200 mg 30 tablets price?Enalapril maleate price trend?Wellbutrin cost without insurance?Goodrx climara pro 4 patches price?
See the DrugPatentWatch profile for symbicort
Symbicort is a combination inhaler that contains: - Budesonide, an inhaled corticosteroid (ICS) that reduces airway inflammation - Formoterol, a long-acting beta2-agonist (LABA) that relaxes airway muscles to improve breathing Together, Symbicort is classified as an ICS/LABA combination therapy for asthma and chronic obstructive pulmonary disease (COPD) in appropriate patients.
Because Symbicort combines an anti-inflammatory medicine (ICS) with a long-acting bronchodilator (LABA), it’s used to control symptoms and reduce flare-ups rather than quickly stop an acute asthma attack (that role is typically for a short-acting rescue inhaler).
Yes—Symbicort’s drug class is the same type as other inhalers that combine an inhaled corticosteroid + a LABA, though the exact drugs (and doses) differ by product (for example, fluticasone/salmeterol or mometasone/formoterol combinations).
Other Questions About Symbicort :